Breast Cancer Research

official impact factor 5.79

Highly Access

PARP inhibitors and the treatment of breast cancer: beyond BRCA1/2?

Kristine M Frizzell and W Lee Kraus*

Breast Cancer Research 2009, 11:111 doi:10.1186/bcr2451


See related research by Inbar-Rozensal et al., http://breast-cancer-research.com/content/11/6/R78

Accesses  

  • Last 30 days: 74 accesses
  • Last 365 days: 1016 accesses
  • All time: 5653 accesses